GL1X · GenesisL1 explorer

MolNFT v1 · #178365 · protein

SARS-cov-2 spike RBDMACSP36 binding to MACE2

7FDK · Angiotensin-converting enzyme 2: “SARS-cov-2 spike RBDMACSP36 binding to MACE2”. Electron microscopy, 1 ligand (NAG), 5 pockets (best druggability 0.71). MolNFT v1 #178365 on GenesisL1: 3D structure, binding sites and pockets in…

PDB
7FDK
Type
protein
Length
791 residues
Chains
2
Method
electron microscopy
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Angiotensin-converting enzyme 2; Spike protein S1
EC
3.4.17.23, 3.4.17.-
UniProt
Q8R0I0, P0DTC2
Ligands
NAG
Pockets
5 · best druggability 0.71

Structure

electron microscopy · 2 distinct chains · 44% helix, 9% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AAngiotensin-converting enzyme 2 (EC 3.4.17.23, 3.4.17.-)protein59754% helix, 4% strandQ8R0I0
ESpike protein S1protein19411% helix, 24% strandP0DTC2

Ligands and binding sites

  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 3 copies · chains A, E

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
17240.710.7870empty
25740.650.7639empty
3620.630.9219empty
41890.540.7934empty
5760.330.7417empty

Interfaces

1 interface between chains.

  • A–E · 904 Ų buried · 11 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 3 disulfide, 3 glycan (disulfide, N-glycosylation).

Compared structures

  • 7FDK · SARS-COV-2 Spike RBDMACSp36 binding to mACE2 · the same entry in another collection · chain A against A, TM-score 1.00
  • Q8R0I0 · AlphaFold monomer V2.0 prediction for angiotensin-converting enzyme 2 (Q8R0I0) · a predicted model of the same protein · chain A against A, TM-score 0.96

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.